Tong Xu

6PUBLICATIONS
12CO-AUTHORS
Biomolecular modelling and designMolecular targetsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 06, 2026
Rational Inhibitor Discovery for BRAFV600E Using PSeMut, a Sequence-Driven Model.

|Sep 22, 2025
Timosaponin A3 Ameliorates Prostate Cancer Progression via Upregulating STARD4 Mediated Cholesterol Metabolism.

Ye Zhi, Luqi Ge, Shaoru Wang

|Jun 12, 2025
Epigenetic Regulation of PEPT2 as a Novel Strategy to Improve the Antitumor Efficacy of Lenalidomide in Clear Cell Renal Cell Carcinoma.

Feifeng Song, Qi Zhang, Zhentao Zhang

|Apr 02, 2025
SPP1-SRD5A3 signaling axis regulated lymph node metastasis by activating Mucin type O glycan biosynthesis.

Tong Xu, Wanli Zhang, Shaobo Gong

|Aug 17, 2024
Ophiopogonin D' inhibited tumour growth and metastasis of anaplastic thyroid cancer by modulating JUN/RGS4 signalling.

Tong Xu, Wanli Zhang, Yiwen Zhang

|Mar 18, 2024
BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability.

Tiefeng Jin, Lingling Ding, Jinming Chen

Pageof 1

Frequent Collaborators

3 joint publications

Yiwen Zhang

2 joint publications

Feifeng Song

1 joint publications

Xiaozhou Zou

1 joint publications

Minghua Ge